Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2025-08-04 00:00:00 ET · period of report 2025-07-19 · accession 0000950170-25-102158 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-04 | 2025-07-31 | HRTX | Duarte Ira | EVP, CFO | M - OptEx | — | +11.7K | 164.2K | +8% | — |
| D | 2025-08-04 | 2025-07-31 | HRTX | Duarte Ira | EVP, CFO | M - OptEx | $0.00 | -11.7K | 163.7K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-31 | M | A | 11,695 | — | 164,218 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 2 | Derivative | Restricted Stock Units | 2025-07-31 | M | D | 11,695 | $0.00 | 163,721 | D | $0.00 · — to — | 11,695 Common Stock | (F2) The number of restricted stock units disclosed on the Reporting Person's Form 4 filed on April 22, 2025, May 2, 2025 and June 17 , 2025 ("Affected Form 4 Filings") were erroneously disclosed as an acquisition in Column 5(A) when it should have been disclosed as a disposition in Column 5(D). All other information in the Affected Form 4 Filings is correct. (F3) The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025). |